Click for best price
Ocular Drug Delivery Market Size, Share 2023
| Market size in 2022 |
US$ 25380 million
|
Forecast Market size by 2030 |
US$ 34760 million
|
| Growth Rate |
CAGR of 4.6% |
Number of Pages |
72 Pages |
This report aims to provide a comprehensive presentation of the global market for Ocular Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ocular Drug Delivery. This report contains market size and forecasts of Ocular Drug Delivery in global, including the following market information:
Global Ocular Drug Delivery Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Ocular Drug Delivery Market Sales, 2018-2023, 2024-2030, (K Doses)
Global top five Ocular Drug Delivery companies in 2022 (%)
The global Ocular Drug Delivery market was valued at US$ 25380 million in 2022 and is projected to reach US$ 34760 million by 2030, at a CAGR of 4.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Ocular Insert Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Ocular Drug Delivery include OCULAR THERAPEUTIX, INC, Alimera Sciences, Allergan, Plc, EyeGate Pharma, Valeant Pharmaceuticals International, Inc, Envisia Therapeutics, Clearside Biomedical, Graybug Vision Inc and Taiwan Liposome Company, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Ocular Drug Delivery manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ocular Drug Delivery Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Doses)
Global Ocular Drug Delivery Market Segment Percentages, by Type, 2022 (%)
Ocular Insert
Iontophoresis
Intraocular Implants
In Situ Gel & Punctal Plugs
Others
Global Ocular Drug Delivery Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Doses)
Global Ocular Drug Delivery Market Segment Percentages, by Application, 2022 (%)
Hospitals
Ambulatory Surgical Centers
Ophthalmic Clinics
Homecare Settings
Global Ocular Drug Delivery Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Doses)
Global Ocular Drug Delivery Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ocular Drug Delivery revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Ocular Drug Delivery revenues share in global market, 2022 (%)
Key companies Ocular Drug Delivery sales in global market, 2018-2023 (Estimated), (K Doses)
Key companies Ocular Drug Delivery sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
OCULAR THERAPEUTIX, INC
Alimera Sciences
Allergan, Plc
EyeGate Pharma
Valeant Pharmaceuticals International, Inc
Envisia Therapeutics
Clearside Biomedical
Graybug Vision Inc
Taiwan Liposome Company
Santen Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ocular Drug Delivery, market overview.
Chapter 2: Global Ocular Drug Delivery market size in revenue and volume.
Chapter 3: Detailed analysis of Ocular Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ocular Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Ocular Drug Delivery capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Ocular Drug Delivery Market, Global Outlook and Forecast 2023-2030 |
| Market size in 2022 |
US$ 25380 million
|
| Forecast Market size by 2030 |
US$ 34760 million
|
| Growth Rate |
CAGR of 4.6% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
72 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Ocular Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ocular Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ocular Drug Delivery Overall Market Size
2.1 Global Ocular Drug Delivery Market Size: 2022 VS 2030
2.2 Global Ocular Drug Delivery Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Ocular Drug Delivery Sales: 2018-2030
3 Company Landscape
3.1 Top Ocular Drug Delivery Players in Global Market
3.2 Top Global Ocular Drug Delivery Companies Ranked by Revenue
3.3 Global Ocular Drug Delivery Revenue by Companies
3.4 Global Ocular Drug Delivery Sales by Companies
3.5 Global Ocular Drug Delivery Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Ocular Drug Delivery Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Ocular Drug Delivery Product Type
3.8 Tier 1, Tier 2 and Tier 3 Ocular Drug Delivery Players in Global Market
3.8.1 List of Global Tier 1 Ocular Drug Delivery Companies
3.8.2 List of Global Tier 2 and Tier 3 Ocular Drug Delivery Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Ocular Drug Delivery Market Size Markets, 2022 & 2030
4.1.2 Ocular Insert
4.1.3 Iontophoresis
4.1.4 Intraocular Implants
4.1.5 In Situ Gel & Punctal Plugs
4.1.6 Others
4.2 By Type - Global Ocular Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global Ocular Drug Delivery Revenue, 2018-2023
4.2.2 By Type - Global Ocular Drug Delivery Revenue, 2024-2030
4.2.3 By Type - Global Ocular Drug Delivery Revenue Market Share, 2018-2030
4.3 By Type - Global Ocular Drug Delivery Sales & Forecasts
4.3.1 By Type - Global Ocular Drug Delivery Sales, 2018-2023
4.3.2 By Type - Global Ocular Drug Delivery Sales, 2024-2030
4.3.3 By Type - Global Ocular Drug Delivery Sales Market Share, 2018-2030
4.4 By Type - Global Ocular Drug Delivery Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Ocular Drug Delivery Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.1.4 Ophthalmic Clinics
5.1.5 Homecare Settings
5.2 By Application - Global Ocular Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global Ocular Drug Delivery Revenue, 2018-2023
5.2.2 By Application - Global Ocular Drug Delivery Revenue, 2024-2030
5.2.3 By Application - Global Ocular Drug Delivery Revenue Market Share, 2018-2030
5.3 By Application - Global Ocular Drug Delivery Sales & Forecasts
5.3.1 By Application - Global Ocular Drug Delivery Sales, 2018-2023
5.3.2 By Application - Global Ocular Drug Delivery Sales, 2024-2030
5.3.3 By Application - Global Ocular Drug Delivery Sales Market Share, 2018-2030
5.4 By Application - Global Ocular Drug Delivery Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Ocular Drug Delivery Market Size, 2022 & 2030
6.2 By Region - Global Ocular Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global Ocular Drug Delivery Revenue, 2018-2023
6.2.2 By Region - Global Ocular Drug Delivery Revenue, 2024-2030
6.2.3 By Region - Global Ocular Drug Delivery Revenue Market Share, 2018-2030
6.3 By Region - Global Ocular Drug Delivery Sales & Forecasts
6.3.1 By Region - Global Ocular Drug Delivery Sales, 2018-2023
6.3.2 By Region - Global Ocular Drug Delivery Sales, 2024-2030
6.3.3 By Region - Global Ocular Drug Delivery Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Ocular Drug Delivery Revenue, 2018-2030
6.4.2 By Country - North America Ocular Drug Delivery Sales, 2018-2030
6.4.3 US Ocular Drug Delivery Market Size, 2018-2030
6.4.4 Canada Ocular Drug Delivery Market Size, 2018-2030
6.4.5 Mexico Ocular Drug Delivery Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Ocular Drug Delivery Revenue, 2018-2030
6.5.2 By Country - Europe Ocular Drug Delivery Sales, 2018-2030
6.5.3 Germany Ocular Drug Delivery Market Size, 2018-2030
6.5.4 France Ocular Drug Delivery Market Size, 2018-2030
6.5.5 U.K. Ocular Drug Delivery Market Size, 2018-2030
6.5.6 Italy Ocular Drug Delivery Market Size, 2018-2030
6.5.7 Russia Ocular Drug Delivery Market Size, 2018-2030
6.5.8 Nordic Countries Ocular Drug Delivery Market Size, 2018-2030
6.5.9 Benelux Ocular Drug Delivery Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Ocular Drug Delivery Revenue, 2018-2030
6.6.2 By Region - Asia Ocular Drug Delivery Sales, 2018-2030
6.6.3 China Ocular Drug Delivery Market Size, 2018-2030
6.6.4 Japan Ocular Drug Delivery Market Size, 2018-2030
6.6.5 South Korea Ocular Drug Delivery Market Size, 2018-2030
6.6.6 Southeast Asia Ocular Drug Delivery Market Size, 2018-2030
6.6.7 India Ocular Drug Delivery Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Ocular Drug Delivery Revenue, 2018-2030
6.7.2 By Country - South America Ocular Drug Delivery Sales, 2018-2030
6.7.3 Brazil Ocular Drug Delivery Market Size, 2018-2030
6.7.4 Argentina Ocular Drug Delivery Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Ocular Drug Delivery Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Ocular Drug Delivery Sales, 2018-2030
6.8.3 Turkey Ocular Drug Delivery Market Size, 2018-2030
6.8.4 Israel Ocular Drug Delivery Market Size, 2018-2030
6.8.5 Saudi Arabia Ocular Drug Delivery Market Size, 2018-2030
6.8.6 UAE Ocular Drug Delivery Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 OCULAR THERAPEUTIX, INC
7.1.1 OCULAR THERAPEUTIX, INC Company Summary
7.1.2 OCULAR THERAPEUTIX, INC Business Overview
7.1.3 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Major Product Offerings
7.1.4 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales and Revenue in Global (2018-2023)
7.1.5 OCULAR THERAPEUTIX, INC Key News & Latest Developments
7.2 Alimera Sciences
7.2.1 Alimera Sciences Company Summary
7.2.2 Alimera Sciences Business Overview
7.2.3 Alimera Sciences Ocular Drug Delivery Major Product Offerings
7.2.4 Alimera Sciences Ocular Drug Delivery Sales and Revenue in Global (2018-2023)
7.2.5 Alimera Sciences Key News & Latest Developments
7.3 Allergan, Plc
7.3.1 Allergan, Plc Company Summary
7.3.2 Allergan, Plc Business Overview
7.3.3 Allergan, Plc Ocular Drug Delivery Major Product Offerings
7.3.4 Allergan, Plc Ocular Drug Delivery Sales and Revenue in Global (2018-2023)
7.3.5 Allergan, Plc Key News & Latest Developments
7.4 EyeGate Pharma
7.4.1 EyeGate Pharma Company Summary
7.4.2 EyeGate Pharma Business Overview
7.4.3 EyeGate Pharma Ocular Drug Delivery Major Product Offerings
7.4.4 EyeGate Pharma Ocular Drug Delivery Sales and Revenue in Global (2018-2023)
7.4.5 EyeGate Pharma Key News & Latest Developments
7.5 Valeant Pharmaceuticals International, Inc
7.5.1 Valeant Pharmaceuticals International, Inc Company Summary
7.5.2 Valeant Pharmaceuticals International, Inc Business Overview
7.5.3 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Major Product Offerings
7.5.4 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales and Revenue in Global (2018-2023)
7.5.5 Valeant Pharmaceuticals International, Inc Key News & Latest Developments
7.6 Envisia Therapeutics
7.6.1 Envisia Therapeutics Company Summary
7.6.2 Envisia Therapeutics Business Overview
7.6.3 Envisia Therapeutics Ocular Drug Delivery Major Product Offerings
7.6.4 Envisia Therapeutics Ocular Drug Delivery Sales and Revenue in Global (2018-2023)
7.6.5 Envisia Therapeutics Key News & Latest Developments
7.7 Clearside Biomedical
7.7.1 Clearside Biomedical Company Summary
7.7.2 Clearside Biomedical Business Overview
7.7.3 Clearside Biomedical Ocular Drug Delivery Major Product Offerings
7.7.4 Clearside Biomedical Ocular Drug Delivery Sales and Revenue in Global (2018-2023)
7.7.5 Clearside Biomedical Key News & Latest Developments
7.8 Graybug Vision Inc
7.8.1 Graybug Vision Inc Company Summary
7.8.2 Graybug Vision Inc Business Overview
7.8.3 Graybug Vision Inc Ocular Drug Delivery Major Product Offerings
7.8.4 Graybug Vision Inc Ocular Drug Delivery Sales and Revenue in Global (2018-2023)
7.8.5 Graybug Vision Inc Key News & Latest Developments
7.9 Taiwan Liposome Company
7.9.1 Taiwan Liposome Company Company Summary
7.9.2 Taiwan Liposome Company Business Overview
7.9.3 Taiwan Liposome Company Ocular Drug Delivery Major Product Offerings
7.9.4 Taiwan Liposome Company Ocular Drug Delivery Sales and Revenue in Global (2018-2023)
7.9.5 Taiwan Liposome Company Key News & Latest Developments
7.10 Santen Pharmaceutical
7.10.1 Santen Pharmaceutical Company Summary
7.10.2 Santen Pharmaceutical Business Overview
7.10.3 Santen Pharmaceutical Ocular Drug Delivery Major Product Offerings
7.10.4 Santen Pharmaceutical Ocular Drug Delivery Sales and Revenue in Global (2018-2023)
7.10.5 Santen Pharmaceutical Key News & Latest Developments
8 Global Ocular Drug Delivery Production Capacity, Analysis
8.1 Global Ocular Drug Delivery Production Capacity, 2018-2030
8.2 Ocular Drug Delivery Production Capacity of Key Manufacturers in Global Market
8.3 Global Ocular Drug Delivery Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Ocular Drug Delivery Supply Chain Analysis
10.1 Ocular Drug Delivery Industry Value Chain
10.2 Ocular Drug Delivery Upstream Market
10.3 Ocular Drug Delivery Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Ocular Drug Delivery Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Ocular Drug Delivery in Global Market
Table 2. Top Ocular Drug Delivery Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Ocular Drug Delivery Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Ocular Drug Delivery Revenue Share by Companies, 2018-2023
Table 5. Global Ocular Drug Delivery Sales by Companies, (K Doses), 2018-2023
Table 6. Global Ocular Drug Delivery Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Ocular Drug Delivery Price (2018-2023) & (USD/Dose)
Table 8. Global Manufacturers Ocular Drug Delivery Product Type
Table 9. List of Global Tier 1 Ocular Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ocular Drug Delivery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Ocular Drug Delivery Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Ocular Drug Delivery Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Ocular Drug Delivery Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Ocular Drug Delivery Sales (K Doses), 2018-2023
Table 15. By Type - Global Ocular Drug Delivery Sales (K Doses), 2024-2030
Table 16. By Application ? Global Ocular Drug Delivery Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Ocular Drug Delivery Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Ocular Drug Delivery Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Ocular Drug Delivery Sales (K Doses), 2018-2023
Table 20. By Application - Global Ocular Drug Delivery Sales (K Doses), 2024-2030
Table 21. By Region ? Global Ocular Drug Delivery Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Ocular Drug Delivery Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Ocular Drug Delivery Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Ocular Drug Delivery Sales (K Doses), 2018-2023
Table 25. By Region - Global Ocular Drug Delivery Sales (K Doses), 2024-2030
Table 26. By Country - North America Ocular Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Ocular Drug Delivery Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Ocular Drug Delivery Sales, (K Doses), 2018-2023
Table 29. By Country - North America Ocular Drug Delivery Sales, (K Doses), 2024-2030
Table 30. By Country - Europe Ocular Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Ocular Drug Delivery Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Ocular Drug Delivery Sales, (K Doses), 2018-2023
Table 33. By Country - Europe Ocular Drug Delivery Sales, (K Doses), 2024-2030
Table 34. By Region - Asia Ocular Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Ocular Drug Delivery Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Ocular Drug Delivery Sales, (K Doses), 2018-2023
Table 37. By Region - Asia Ocular Drug Delivery Sales, (K Doses), 2024-2030
Table 38. By Country - South America Ocular Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Ocular Drug Delivery Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Ocular Drug Delivery Sales, (K Doses), 2018-2023
Table 41. By Country - South America Ocular Drug Delivery Sales, (K Doses), 2024-2030
Table 42. By Country - Middle East & Africa Ocular Drug Delivery Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Ocular Drug Delivery Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Ocular Drug Delivery Sales, (K Doses), 2018-2023
Table 45. By Country - Middle East & Africa Ocular Drug Delivery Sales, (K Doses), 2024-2030
Table 46. OCULAR THERAPEUTIX, INC Company Summary
Table 47. OCULAR THERAPEUTIX, INC Ocular Drug Delivery Product Offerings
Table 48. OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 49. OCULAR THERAPEUTIX, INC Key News & Latest Developments
Table 50. Alimera Sciences Company Summary
Table 51. Alimera Sciences Ocular Drug Delivery Product Offerings
Table 52. Alimera Sciences Ocular Drug Delivery Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 53. Alimera Sciences Key News & Latest Developments
Table 54. Allergan, Plc Company Summary
Table 55. Allergan, Plc Ocular Drug Delivery Product Offerings
Table 56. Allergan, Plc Ocular Drug Delivery Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 57. Allergan, Plc Key News & Latest Developments
Table 58. EyeGate Pharma Company Summary
Table 59. EyeGate Pharma Ocular Drug Delivery Product Offerings
Table 60. EyeGate Pharma Ocular Drug Delivery Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 61. EyeGate Pharma Key News & Latest Developments
Table 62. Valeant Pharmaceuticals International, Inc Company Summary
Table 63. Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Product Offerings
Table 64. Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 65. Valeant Pharmaceuticals International, Inc Key News & Latest Developments
Table 66. Envisia Therapeutics Company Summary
Table 67. Envisia Therapeutics Ocular Drug Delivery Product Offerings
Table 68. Envisia Therapeutics Ocular Drug Delivery Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 69. Envisia Therapeutics Key News & Latest Developments
Table 70. Clearside Biomedical Company Summary
Table 71. Clearside Biomedical Ocular Drug Delivery Product Offerings
Table 72. Clearside Biomedical Ocular Drug Delivery Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 73. Clearside Biomedical Key News & Latest Developments
Table 74. Graybug Vision Inc Company Summary
Table 75. Graybug Vision Inc Ocular Drug Delivery Product Offerings
Table 76. Graybug Vision Inc Ocular Drug Delivery Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 77. Graybug Vision Inc Key News & Latest Developments
Table 78. Taiwan Liposome Company Company Summary
Table 79. Taiwan Liposome Company Ocular Drug Delivery Product Offerings
Table 80. Taiwan Liposome Company Ocular Drug Delivery Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 81. Taiwan Liposome Company Key News & Latest Developments
Table 82. Santen Pharmaceutical Company Summary
Table 83. Santen Pharmaceutical Ocular Drug Delivery Product Offerings
Table 84. Santen Pharmaceutical Ocular Drug Delivery Sales (K Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2018-2023)
Table 85. Santen Pharmaceutical Key News & Latest Developments
Table 86. Ocular Drug Delivery Production Capacity (K Doses) of Key Manufacturers in Global Market, 2021-2023 (K Doses)
Table 87. Global Ocular Drug Delivery Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Ocular Drug Delivery Production by Region, 2018-2023 (K Doses)
Table 89. Global Ocular Drug Delivery Production by Region, 2024-2030 (K Doses)
Table 90. Ocular Drug Delivery Market Opportunities & Trends in Global Market
Table 91. Ocular Drug Delivery Market Drivers in Global Market
Table 92. Ocular Drug Delivery Market Restraints in Global Market
Table 93. Ocular Drug Delivery Raw Materials
Table 94. Ocular Drug Delivery Raw Materials Suppliers in Global Market
Table 95. Typical Ocular Drug Delivery Downstream
Table 96. Ocular Drug Delivery Downstream Clients in Global Market
Table 97. Ocular Drug Delivery Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Ocular Drug Delivery Segment by Type in 2022
Figure 2. Ocular Drug Delivery Segment by Application in 2022
Figure 3. Global Ocular Drug Delivery Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Ocular Drug Delivery Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Ocular Drug Delivery Revenue, 2018-2030 (US$, Mn)
Figure 7. Ocular Drug Delivery Sales in Global Market: 2018-2030 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Ocular Drug Delivery Revenue in 2022
Figure 9. By Type - Global Ocular Drug Delivery Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Ocular Drug Delivery Revenue Market Share, 2018-2030
Figure 11. By Type - Global Ocular Drug Delivery Sales Market Share, 2018-2030
Figure 12. By Type - Global Ocular Drug Delivery Price (USD/Dose), 2018-2030
Figure 13. By Application - Global Ocular Drug Delivery Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Ocular Drug Delivery Revenue Market Share, 2018-2030
Figure 15. By Application - Global Ocular Drug Delivery Sales Market Share, 2018-2030
Figure 16. By Application - Global Ocular Drug Delivery Price (USD/Dose), 2018-2030
Figure 17. By Region - Global Ocular Drug Delivery Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Ocular Drug Delivery Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Ocular Drug Delivery Revenue Market Share, 2018-2030
Figure 20. By Region - Global Ocular Drug Delivery Sales Market Share, 2018-2030
Figure 21. By Country - North America Ocular Drug Delivery Revenue Market Share, 2018-2030
Figure 22. By Country - North America Ocular Drug Delivery Sales Market Share, 2018-2030
Figure 23. US Ocular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Ocular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Ocular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Ocular Drug Delivery Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Ocular Drug Delivery Sales Market Share, 2018-2030
Figure 28. Germany Ocular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 29. France Ocular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Ocular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Ocular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Ocular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Ocular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Ocular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Ocular Drug Delivery Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Ocular Drug Delivery Sales Market Share, 2018-2030
Figure 37. China Ocular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Ocular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Ocular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Ocular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 41. India Ocular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Ocular Drug Delivery Revenue Market Share, 2018-2030
Figure 43. By Country - South America Ocular Drug Delivery Sales Market Share, 2018-2030
Figure 44. Brazil Ocular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Ocular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Ocular Drug Delivery Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Ocular Drug Delivery Sales Market Share, 2018-2030
Figure 48. Turkey Ocular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Ocular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Ocular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Ocular Drug Delivery Revenue, (US$, Mn), 2018-2030
Figure 52. Global Ocular Drug Delivery Production Capacity (K Doses), 2018-2030
Figure 53. The Percentage of Production Ocular Drug Delivery by Region, 2022 VS 2030
Figure 54. Ocular Drug Delivery Industry Value Chain
Figure 55. Marketing Channels
